Outcome | Parameter | Group | Crude Analysis | Adjusted Combined Analysisa | ||
---|---|---|---|---|---|---|
P Value | Odds Ratio (95% CIb) | P Value | Odds Ratio (95% CI) | |||
Severe to Critical COVID-19 | Periodontitis Severity | HPc | - | 1.0 | - | 1.0 |
MP | 0.544 | 1.350 (0.513 – 3.556) | 0.528 | 1.551 (0.397 – 6.052) | ||
SP | < 0.001* | 7.855 (2.896 – 21.305) | 0.047* | 4.247 (1.020 – 17.683) | ||
Serum IL-6 | - | 0.002* | 1.049 (1.017 – 1.082) | 0.033* | 1.075 (1.006 – 1.148) | |
Saliva IL-6 | - | 0.009* | 1.147 (1.035 – 1.272) | - | - | |
Serum CRP | - | 0.097 | 1.014 (0.998 – 1.030) | 0.495 | 0.991 (0.966 – 1.017) | |
Saliva CRP | - | 0.333 | 1.084 (0.920 – 1.277) | - | - | |
Mean CAL | - | < 0.001* | 1.857 (1.424 – 2.423) | - | - | |
Mean GI | - | 0.003* | 1.907 (1.242 – 2.926) | - | - | |
Mean MSBI | - | 0.003* | 2.059 (1.277 – 3.322) | - | - | |
Remaining Teeth | - | < 0.001* | 0.807 (0.728 – 0.894) | - | - | |
Age | - | 0.006* | 1.042 (1.012 – 1.073) | 0.109 | 1.042 (0.991 – 1.095) | |
Sex | Femalec | - | 1.0 | - | 1.0 | |
Male | 0.694 | 1.154 (0.565 – 2.354) | 0.466 | 0.646 (0.2 – 2.088) | ||
Comorbidity | Noc | - | 1.0 | - | 1.0 | |
Yes | 0.045* | 2.211 (1.016 – 4.809) | 0.370 | 1.732 (0.521 – 5.755) |